Money Concepts Capital Corp Sells 224 Shares of Danaher Co. (NYSE:DHR)

Money Concepts Capital Corp lessened its holdings in Danaher Co. (NYSE:DHR) by 2.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 8,331 shares of the conglomerate’s stock after selling 224 shares during the quarter. Money Concepts Capital Corp’s holdings in Danaher were worth $1,912,000 at the end of the most recent reporting period.

Several other hedge funds have also added to or reduced their stakes in DHR. Heck Capital Advisors LLC bought a new position in shares of Danaher during the fourth quarter valued at $27,000. Decker Retirement Planning Inc. acquired a new stake in Danaher in the fourth quarter valued at $31,000. Teachers Insurance & Annuity Association of America bought a new position in Danaher during the 3rd quarter worth $39,000. MidAtlantic Capital Management Inc. acquired a new position in Danaher during the 3rd quarter worth about $40,000. Finally, FSA Wealth Management LLC bought a new stake in shares of Danaher in the 3rd quarter valued at about $50,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Stock Performance

NYSE DHR opened at $211.92 on Thursday. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The company has a fifty day simple moving average of $234.50 and a 200 day simple moving average of $252.68. Danaher Co. has a 12-month low of $210.04 and a 12-month high of $281.70. The company has a market cap of $153.07 billion, a P/E ratio of 40.14, a PEG ratio of 2.80 and a beta of 0.83.

Danaher (NYSE:DHR) last posted its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, hitting the consensus estimate of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same quarter in the prior year, the firm earned $2.09 earnings per share. Sell-side analysts predict that Danaher Co. will post 7.77 earnings per share for the current fiscal year.

Danaher Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, January 31st. Stockholders of record on Friday, December 27th were issued a $0.27 dividend. The ex-dividend date of this dividend was Friday, December 27th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.51%. Danaher’s dividend payout ratio is presently 20.45%.

Insider Activity at Danaher

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of Danaher stock in a transaction on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the transaction, the senior vice president now directly owns 20,230 shares of the company’s stock, valued at $4,534,149.90. The trade was a 21.98 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 10.90% of the stock is owned by insiders.

Analyst Ratings Changes

A number of brokerages have recently issued reports on DHR. Bank of America upgraded Danaher from a “neutral” rating to a “buy” rating and set a $290.00 price objective for the company in a research report on Friday, December 13th. Stephens restated an “overweight” rating and issued a $315.00 price target on shares of Danaher in a research report on Wednesday, October 23rd. TD Cowen increased their price objective on shares of Danaher from $310.00 to $315.00 and gave the stock a “buy” rating in a research report on Wednesday, October 23rd. Raymond James restated a “market perform” rating on shares of Danaher in a report on Monday. Finally, Wolfe Research upgraded Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 price target for the company in a report on Thursday, October 31st. Seven equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat.com, Danaher has a consensus rating of “Moderate Buy” and an average target price of $278.00.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.